SARAH ARNOLD: Open Payments
NPI 1114655123 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 75 payments from 20 companies in 2025. Trend: 2023 $1,121 · 2024 $1,441 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $191 |
| PFIZER INC. | 13 | $153 |
| AstraZeneca Pharmaceuticals LP | 5 | $152 |
| Lilly USA, LLC | 7 | $134 |
| ABBVIE INC. | 6 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Novo Nordisk Inc | 3 | $49 |
| Exact Sciences Corporation | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $43 |
Products named: MOUNJARO, EVENITY, AIRSUPRA, REXULTI, UBRELVY, TRELEGY ELLIPTA, OTEZLA, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
